PATRICE SMITH: Open Payments
NPI 1467159426 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366 in 12 payments from 9 companies in 2025. Trend: 2023 $85 · 2024 $128 · 2025 $366
Food & beverage: $366
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $165 |
| ABBVIE INC. | 2 | $43 |
| Alkermes, Inc. | 1 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Gilead Sciences, Inc. | 1 | $22 |
| Braeburn Inc. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Indivior Inc. | 1 | $17 |
| Orexo US, Inc. | 1 | $15 |
Products named: CAPLYTA, MAVYRET, VIVITROL, REXULTI, BRIXADI, SPRAVATO, SUBLOCADE, Zubsolv.
Industry payments across IN — which companies pay providers there.
